Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

NSPR

InspireMD, Inc.

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1433607Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$9.0M
Net Income FY2025
$(49.0M)
EPS (Basic, as reported)
$-0.76
Net Margin FY2025
-543.3%
ROE FY2025
-88.4%
Total Equity
$55.0M
Shares Out
46M
Business description

InspireMD, Inc. — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 2 → 9 +18.2% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022⚑FY2023⚑FY2024⚑FY2025
Revenue2344245679
Cost of revenue(2)(2)(3)(3)(2)(4)(4)(4)(6)(6)
Gross profit0111011223
Research & development(1)(1)(2)(3)(2)(5)(8)(8)(14)(15)
Selling & marketing(1)(2)(2)(2)(2)(3)(4)(4)(6)(17)
General & administrative(5)(5)(5)(5)(6)(7)(8)(11)(15)(21)
Total operating expenses(8)(9)(9)(11)(10)(15)(20)(23)(35)(52)
Operating income(8)(8)(8)(10)(10)(15)(19)(21)(34)(50)
Interest expense(1)0————————
Interest & investment income——————————
Other income (expense), net——00000121
Pre-tax income(8)(8)(7)(10)(11)(15)(18)(20)(32)(49)
Income tax expense00—0000000
Net income(8)(8)(7)(10)(11)(15)(18)(20)(32)(49)
EPS — basic—————($2.03)($2.35)($0.82)($0.76)($0.76)
EPS — diluted——————($2.35)($0.82)($0.76)($0.76)
Shares outstanding — basic (M)—————78244264
Shares outstanding — diluted (M)——————8244264

Showing the latest 10 of 17 fiscal years.

  • ⚑ Weighted-average shares changed ×3.00 between FY2022 and FY2023 — likely a stock split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×1.75 between FY2023 and FY2024 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×1.52 between FY2024 and FY2025 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.